0001610717-24-000194.txt : 20240329
0001610717-24-000194.hdr.sgml : 20240329
20240329161814
ACCESSION NUMBER: 0001610717-24-000194
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240329
DATE AS OF CHANGE: 20240329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eizen Joshua M
CENTRAL INDEX KEY: 0001949621
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41331
FILM NUMBER: 24804322
MAIL ADDRESS:
STREET 1: 3023 MONTBRETIA WAY
CITY: SAN RAMON
STATE: CA
ZIP: 94582
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AN2 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001880438
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 820606654
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 EL CAMINO REAL, SUITE D
CITY: MENLO PARK
STATE: CA
ZIP: 94027
BUSINESS PHONE: (650) 331-9090
MAIL ADDRESS:
STREET 1: 1800 EL CAMINO REAL, SUITE D
CITY: MENLO PARK
STATE: CA
ZIP: 94027
4/A
1
form4.xml
X0508
4/A
2024-03-15
2024-03-18
0001880438
AN2 Therapeutics, Inc.
ANTX
0001949621
Eizen Joshua M
C/O AN2 THERAPEUTICS, INC.
1800 EL CAMINO REAL, SUITE D
MENLO PARK
CA
94027
true
Chief Legal Officer
false
Common Stock
2024-03-15
4
A
0
30000
0
A
32447
D
Previously reported on a Form 4 filed on March 18, 2024. As amended, the vesting schedule for the restricted stock units is as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
/s/ Lucy Day, Attorney-in-Fact for Joshua M. Eizen
2024-03-29